Novanta NOVT Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Automation Enabling Technologies | $500.84M+2.1% | $490.62M-1.7% | $499.22M-6.5% | $534.09M— | |
| Medical Solutions | $479.76M+4.6% | $458.63M+19.9% | $382.44M+17.0% | $326.81M+24.7% | |
| Robotics And Automation | $318.58M+10.5% | $288.32M+5.4% | $273.47M-11.3% | $308.24M+45.2% | |
| Segment Operating Income by Business | |||||
| Automation Enabling Technologies | $114.53M+7.6% | $106.4M+10.5% | $96.28M-8.7% | $105.43M— | |
| Medical Solutions | $51.17M-11.1% | $57.53M-9.1% | $63.26M+35.0% | $46.87M— | |
| Gross Profit by Business | |||||
| Automation Enabling Technologies | $239.51M+1.9% | $234.97M+0.1% | $234.8M-4.2% | $245.01M— | |
| Medical Solutions | $199.7M+5.1% | $189.96M+11.2% | $170.79M+22.8% | $139.03M+37.8% | |
| Income Tax Paid Foreign After Refund Received by Business | |||||
| Corporate | $12.65M— | —— | —— | —— | |
| Trade | $9.89M— | —— | —— | —— | |
| Accounts Receivable Net Current by Business | |||||
| Automation Enabling Technologies | $293.83M— | —— | —— | —— | |
| Medical Solutions | $387.02M— | —— | —— | —— | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest by Business | |||||
| Automation Enabling Technologies | $114.53M+7.6% | $106.4M+10.5% | $96.28M-8.7% | $105.43M— | |
| Medical Solutions | $51.17M-11.1% | $57.53M-9.1% | $63.26M+35.0% | $46.87M— | |
| Inventory Net by Business | |||||
| Automation Enabling Technologies | $397.45M— | —— | —— | —— | |
| Medical Solutions | $284.31M— | —— | —— | —— | |
| Selling General And Administrative Expense by Business | |||||
| Automation Enabling Technologies | $76.32M+1.2% | $75.42M+3.5% | $72.86M-0.9% | $73.55M— | |
| Medical Solutions | $60.03M+11.6% | $53.8M+9.3% | $49.23M+15.5% | $42.63M— | |
| Restructuring Costs by Business | |||||
| Automation Enabling Technologies | -$3.11M-197% | $3.2M-52.8% | $6.77M+144% | $2.78M— | |
| Medical Solutions | $7.41M+9.4% | $6.77M+376% | $1.42M+555% | $217K-73.3% | |
| Unallocated Costs | $3.43M+560% | $519K-37.5% | $831K+41,450% | $2K— | |
| Cost of Goods Sold by Business | |||||
| Automation Enabling Technologies | $255.76M+2.6% | $249.37M-3.1% | $257.38M-8.6% | $281.69M— | |
| Medical Solutions | $269.36M+3.5% | $260.18M+26.0% | $206.55M+13.5% | $181.91M— | |
| D&A by Business | |||||
| Automation Enabling Technologies | $22.44M-6.0% | $23.87M-10.5% | $26.68M-17.5% | $32.33M— | |
| Medical Solutions | $37.96M+27.3% | $29.82M+60.5% | $18.58M-9.0% | $20.43M-1.9% | |
| Goodwill Gross by Business | |||||
| Automation Enabling Technologies | $1.77B— | —— | —— | —— | |
| Medical Solutions | $1.36B+21.4% | $1.12B+58.6% | $708.04M— | —— | |
| Amortization Of Intangible Assets by Business | |||||
| Automation Enabling Technologies | $9.77M-12.8% | $11.21M-13.4% | $12.94M-26.7% | $17.66M— | |
| Medical Solutions | $17.71M+21.4% | $14.59M+94.4% | $7.5M-13.5% | $8.68M— | |
| Research And Development Expense by Business | |||||
| Automation Enabling Technologies | $37.8M-3.1% | $39.03M-9.3% | $43.02M-5.3% | $45.44M— | |
| Medical Solutions | $58.34M+2.2% | $57.11M+15.5% | $49.44M+22.3% | $40.42M— | |
| Restructuring Charges And Acquisition Related Costs by Business | |||||
| Automation Enabling Technologies | $1.08M-62.8% | $2.92M-69.9% | $9.69M+232% | $2.92M— | |
| Medical Solutions | $12.45M+79.6% | $6.93M+410% | $1.36M+215% | $432K— | |
| Cost Of Goods And Services Sold Amortization by Business | |||||
| Automation Enabling Technologies | $5.57M-11.3% | $6.28M-10.9% | $7.05M-4.7% | $7.4M— | |
| Medical Solutions | $10.71M+26.1% | $8.49M+66.3% | $5.11M-13.1% | $5.87M— | |
| Goodwill Impaired Accumulated Impairment Loss by Business | |||||
| Automation Enabling Technologies | $478.03M— | —— | —— | —— | |
| Medical Solutions | $126.89M0.0% | $126.89M0.0% | $126.89M— | —— | |
| Goodwill by Business | |||||
| Automation Enabling Technologies | $1.3B— | —— | —— | —— | |
| Medical Solutions | $1.24B+24.1% | $995.87M+71.4% | $581.15M— | —— | |
| Revenue by Geography | |||||
| CN | $93.2M+10.2% | $84.56M+15.1% | $73.44M-24.4% | $97.18M+2.2% | |
| DE | $114.65M-7.0% | $123.24M-3.9% | $128.23M-4.1% | $133.73M+31.3% | |
| Other Countries | $19.31M+4.9% | $18.4M-4.9% | $19.35M-2.6% | $19.87M+80.8% | |
| Rest Of Asia Pacific | $97.03M-9.4% | $107.05M+1.6% | $105.35M+5.3% | $100.01M+12.1% | |
| Rest Of Europe | $137.41M+6.6% | $128.87M-6.0% | $137.03M-0.5% | $137.76M-0.8% | |
| US | $519.01M+6.5% | $487.11M+16.5% | $418.27M+12.3% | $372.35M+37.5% | |
| Open Tax Year by Geography | |||||
| CA | $2.02K+0.2% | $2.02K0.0% | $2.02K0.0% | $2.02K0.0% | |
| CN | $2.02K0.0% | $2.01K0.0% | $2.01K0.0% | $2.01K0.0% | |
| CZ | $2.02K0.0% | $2.02K0.0% | $2.02K— | —— | |
| DE | $2.02K+0.2% | $2.02K0.0% | $2.02K0.0% | $2.02K0.0% | |
| GB | $2.02K0.0% | $2.02K+0.1% | $2.02K0.0% | $2.02K0.0% | |
| JP | $2.02K0.0% | $2.02K0.0% | $2.02K0.0% | $2.02K0.0% | |
| US | $2.02K0.0% | $2.02K0.0% | $2.02K0.0% | $2.02K0.0% | |
| Current Income Tax Expense Benefit by Geography | |||||
| CA | $11K-74.4% | $43K-27.1% | $59K-9.2% | $65K-31.6% | |
| US | $1.73M-84.5% | $11.2M-22.4% | $14.42M-16.2% | $17.21M+8,293% | |
| Concentration Risk % by Geography | |||||
| Other Countries | 2%+0.1pp | 1.9%-0.3pp | 2.2%+0.1pp | 2.1%+0.5pp | |
| Rest Of Asia Pacific | 9.9%-1.4pp | 11.3%-0.7pp | 12%+0.2pp | 11.8%-0.8pp | |
| Rest Of Europe | 14%+0.4pp | 13.6%-2.0pp | 15.6%-0.4pp | 16%-3.6pp | |
| Tax Credit Carryforward Expiration Year by Geography | |||||
| US Federal Foreign Tax Credits | 2K0.0% | 2K— | —— | —— | |
| US State Credits | 2K+0.3% | 2K— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Novanta break its business down?
- Novanta (NOVT) reports revenue by business across 3 parts — Automation Enabling Technologies, Medical Solutions and Robotics And Automation. Each is extracted from the segment footnotes and tracked over time.
- Where does Novanta's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Novanta's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.